 RESEARCH TRIANGLE PARK, N.C.--BUSINESS WIRE--TransEnterix, Inc. NYSE American:TRXC, a medical device company that is digitizing the interface between the surgeon and the patient to improve minimally invasive surgery, today announced the closing of its previously announced underwritten public offering of its common stock. Including the full exercise of the underwriters option to purchase additional shares, the Company issued 26,545,832 shares at a public offering price of 3.00 per share. T 